Nova R Wealth, Inc. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 305 filers reported holding NOVOCURE LTD in Q3 2022. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nova R Wealth, Inc. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$293,032
-29.4%
7,061
+2.3%
0.20%
-30.2%
Q1 2023$415,026
-25.6%
6,901
-9.2%
0.28%
-31.3%
Q4 2022$557,753
+3.1%
7,604
+6.9%
0.41%
-7.3%
Q3 2022$541,000
+9.1%
7,116
-0.2%
0.44%
+8.1%
Q2 2022$496,000
-13.7%
7,132
+2.7%
0.41%
-16.9%
Q1 2022$575,000
-16.1%
6,943
-28.9%
0.49%
-11.4%
Q4 2021$685,0009,7670.55%
Other shareholders
NOVOCURE LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders